Michael Messinger
Director/Board Member at FILAMENT HEALTH CORP.
Net worth: 1 $ as of 30/03/2024
Profile
Michael Messinger is currently the Director at Filament Health Corp.
He previously worked as the Finance Director at Lexicon Pharmaceuticals, Inc. from 2001 to 2012.
Before that, he was an Auditor at Ernst & Young LLP from 1996 to 1999 and a Controller at Coelacanth Corp.
from 1999 to 2001.
From 2012 to 2023, he served as the President, Chief Executive & Operating Officer at ContraFect Corp.
Mr. Messinger obtained his undergraduate degree from the University of Michigan.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CONTRAFECT CORP.
0.00% | 05/09/2023 | 23 ( 0.00% ) | 1 $ | 30/03/2024 |
Michael Messinger active positions
| Companies | Position | Start |
|---|---|---|
| FILAMENT HEALTH CORP. | Director/Board Member | 27/03/2024 |
Former positions of Michael Messinger
| Companies | Position | End |
|---|---|---|
| CONTRAFECT CORPORATION | Chief Executive Officer | 03/12/2023 |
| LEXICON PHARMACEUTICALS, INC. | Director of Finance/CFO | 31/12/2011 |
Coelacanth Corp.
 Coelacanth Corp. Miscellaneous Commercial ServicesCommercial Services Coelacanth Corp. is a company that researches drug development. The company is based in East Windsor, NJ. The company was founded by Robert Grubbs. Coelacanth was acquired by Lexicon Pharmaceuticals, Inc. on 2001-07-12 for $31.9 million. | Comptroller/Controller/Auditor | 31/12/2000 |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Comptroller/Controller/Auditor | 31/12/1998 |
Training of Michael Messinger
| University of Michigan | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| CONTRAFECT CORPORATION | Health Technology |
| LEXICON PHARMACEUTICALS, INC. | Health Technology |
| FILAMENT HEALTH CORP. | Health Technology |
| Private companies | 2 |
|---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
Coelacanth Corp.
Coelacanth Corp. Miscellaneous Commercial ServicesCommercial Services Coelacanth Corp. is a company that researches drug development. The company is based in East Windsor, NJ. The company was founded by Robert Grubbs. Coelacanth was acquired by Lexicon Pharmaceuticals, Inc. on 2001-07-12 for $31.9 million. | Commercial Services |
- Stock Market
- Insiders
- Michael Messinger
